We are live on ! Find out more
RYZB

RayzeBio, Inc. Common Stock
RYZB

Delisted

RYZB was delisted on the 23rd of February, 2024.

Back to rankings

68 hedge funds and large institutions have $1.2B invested in RayzeBio, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 68 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
68
Holders Change
+68
Holders Change %
–
% of All Funds
1.08%
Holding in Top 10
8
Holding in Top 10 Change
+8
Holding in Top 10 Change %
% of All Funds
0.13%
New
68
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Viking Global Investors
Viking Global Investors
Connecticut
+$139M
2
VP
venBio Partners
California
+$108M
3
VVM
Versant Venture Management
California
+$108M
4
VA
VR Adviser
New York
+$84.3M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$81.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MIM
51
Monashee Investment Management
Massachusetts
$611K +$577K +27,500 New
Manulife (Manufacturers Life Insurance)
52
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$560K +$530K +25,235 New
Alyeska Investment Group
53
Alyeska Investment Group
Illinois
$555K +$525K +25,000 New
Citigroup
54
Citigroup
New York
$553K +$523K +24,907 New
GCM
55
Ghisallo Capital Management
Massachusetts
$444K +$420K +20,000 New
SFM
56
Soros Fund Management
New York
$444K +$420K +20,000 New
Susquehanna International Group
57
Susquehanna International Group
Pennsylvania
$431K +$408K +19,419 New
TRSOTSOK
58
Teachers Retirement System of the State of Kentucky
Kentucky
$425K +$402K +19,131 New
Squarepoint
59
Squarepoint
New York
$370K +$350K +16,653 New
Walleye Capital
60
Walleye Capital
New York
$330K +$312K +14,847 New
Qube Research & Technologies (QRT)
61
Qube Research & Technologies (QRT)
United Kingdom
$317K +$300K +14,300 New
Morgan Stanley
62
Morgan Stanley
New York
$251K +$237K +11,295 New
BlackRock
63
BlackRock
New York
$222K +$210K +10,000 New
Norges Bank
64
Norges Bank
Norway
$222K +$210K +10,000 New
UBS Group
65
UBS Group
Switzerland
$75.7K +$71.6K +3,409 New
New York State Common Retirement Fund
66
New York State Common Retirement Fund
New York
$22.2K +$21K +1,000 New
Legal & General Group
67
Legal & General Group
United Kingdom
$22.1K +$21K +1,000 New
TRCT
68
Tower Research Capital (TRC)
New York
$3.64K +$3.44K +164 New
1 2
3

RYZB Hedge Fund Activity: Q3 2023 in Review

68 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in RayzeBio, Inc. Common Stock (RYZB) for Q3 2023, worth a combined $1.2B.

Buyers outnumbered sellers: 68 funds opened new RYZB positions and 0 closed out — a net gain of 68 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Viking Global Investors, opening a new position worth an estimated $139M.

  • 68 institutional investors held RayzeBio, Inc. Common Stock (RYZB) as of Q3 2023, up from 0 in Q2 2023.
  • Funds reported $1.2B of RayzeBio, Inc. Common Stock stock for Q3 2023.
  • 68 funds opened new RayzeBio, Inc. Common Stock positions in Q3 2023 and 0 closed out, a net change of +68 holders.
  • The largest RayzeBio, Inc. Common Stock buyer in Q3 2023 was Viking Global Investors, an estimated $139M added.

Based on aggregated 13F filings for Q3 2023.